Putting the UK back on the map for clinical trials: NWEH par...
The state of clinical trials in the UK has been a central topic of discussion for some years now, but keenly so since Brexit and following the COVID-19 pandemic.
Coming soon: The Life Sciences Industry Report 2025 – insigh...
Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
Part 2 - Accelerating the Medical, Legal and regulatory (MLR...
Medical, legal, and regulatory review (MLR review) of promotional as well as non-promotional materials is one of the core responsibilities of medical and commercial teams within any life sc
Court sides with EU on decision to revoke Ocaliva's license
Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Trump puts final piece in his MAHA puzzle with NIH nominee
President-elect Donald Trump has chosen Stanford health economist Dr Jay Bhattacharya to lead the NIH
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Neuroscience Innovation Pharma Partnering Summit
Significant breakthroughs in CNS biology, coupled with innovative neuroscience technologies and a more supportive regulatory landscape, have fuelled increased investment and pharmaceutical interest
8th Gene Therapy Development Summit
With 14 new gene therapy approvals in the last 18 months, billion-dollar collaborations, and the development of treatments for more common conditions, the gene therapy field is rapidly gaining mome
4th Cell Therapy Potency Assay Summit
In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical.
10th Innate Killer Summit
With recent expansion into autoimmune pipelines, the year of the ‘bounce back’ now feels in reach for the NK space.
15th World ADC London 2025
Europe’s Longest Standing & Definitive Antibody-Drug Conjugate Event